Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Carboplatin and Paclitaxel in HNSCC
NCT01333085Phase 2Completed
- Sponsor
- GERCOR
- Start
- Oct 2009
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in head and neck squamous cell carcinoma (HNSCC), sponsored by GERCOR. Started Oct 2009; status: completed.
02
Drugs
everolimus
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01333085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333085.